These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 12002601)
1. Double cancer, cholangiocellular and hepatocellular carcinomas, in the cirrhotic liver. Yoshikawa T; Hirota S; Matsumoto S; Izaki K; Fukuda T; Sugimura K; Maeda S; Kitagaki H Radiat Med; 2002; 20(1):33-6. PubMed ID: 12002601 [TBL] [Abstract][Full Text] [Related]
2. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy]. Tischoff I; Tannapfel A Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632 [TBL] [Abstract][Full Text] [Related]
3. A case of metachronous cholangiocellular and hepatocellular carcinoma with good prognosis. Kosone T; Takagi H; Hamada T; Kakizaki S; Takehara K; Ohwada S; Mori M Hepatogastroenterology; 2005; 52(64):1228-32. PubMed ID: 16001668 [TBL] [Abstract][Full Text] [Related]
4. [Intraarterial and intraportal chemotherapy combined with decollateralization for cholangiocellular carcinoma and metastatic liver cancer]. Nagano H; Sasaki Y; Imaoka S; Masutani S; Ohashi I; Ishikawa O; Oohigashi H; Yasuda T; Furukawa H; Fukuda I Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1758-62. PubMed ID: 2167649 [TBL] [Abstract][Full Text] [Related]
5. Double primary liver cancer (intrahepatic cholangiocarcinoma and hepatocellular carcinoma) in a patient with hepatitis C virus-related cirrhosis. Inaba K; Suzuki S; Sakaguchi T; Kobayasi Y; Takehara Y; Miura K; Baba S; Nakamura S; Konno H J Hepatobiliary Pancreat Surg; 2007; 14(2):204-9. PubMed ID: 17384916 [TBL] [Abstract][Full Text] [Related]
6. Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients. Nagafuchi Y; Okamoto K; Shono M; Higure A; Todoroki H; Itoh H; Takeda S; Katumoto F; Toyoshima S Hepatogastroenterology; 1998; 45(20):523-7. PubMed ID: 9638442 [TBL] [Abstract][Full Text] [Related]
7. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules. Kwon Y; Lee SK; Kim JS; Ro JY; Yu E Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757 [TBL] [Abstract][Full Text] [Related]
8. Resected case of a double cancer, a hepatocellular carcinoma and a cholangiocellular carcinoma, and their spread to the skin. Suzuki H; Kuwano H; Masuda N; Hashimoto S; Saitoh T; Kanoh K; Nomoto K; Shimura T Hepatogastroenterology; 2003; 50(50):362-5. PubMed ID: 12749221 [TBL] [Abstract][Full Text] [Related]
9. [Three cases of hepatocellular carcinoma, over 3 cm in diameter, with liver cirrhosis treated with combination of radiofrequency ablation and continuous hepatic arterial infusion chemotherapy]. Hirashita T; Nakashima K; Sakai M; Sakai I Gan To Kagaku Ryoho; 2007 Jul; 34(7):1123-6. PubMed ID: 17637554 [TBL] [Abstract][Full Text] [Related]
10. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428 [TBL] [Abstract][Full Text] [Related]
11. [Epidemiology of primary and secondary liver cancers]. Jepsen P; Kissmeyer-Nielsen P Ugeskr Laeger; 2008 Apr; 170(16):1323-5. PubMed ID: 18433588 [TBL] [Abstract][Full Text] [Related]
12. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881 [TBL] [Abstract][Full Text] [Related]
13. Minute mixed hepatoma with two components: hepatocellular and cholangiocarcinoma, which developed on liver cirrhosis with HCV. Tanaka T; Imamura A; Hayashi S; Tsuruta K; Igari T; Koike M; Tanaka S Hepatogastroenterology; 1998; 45(19):220-3. PubMed ID: 9496517 [TBL] [Abstract][Full Text] [Related]
14. [Increased incidence of hepatocellular and intrahepatic cholangiocellular carcinoma in northeast Germany]. Schurr R; Stölzel U; Schuppan D; Schwertner C; Steinberg J; Scherübl H Dtsch Med Wochenschr; 2006 Jul; 131(30):1649-55. PubMed ID: 16850381 [TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma. Watanabe M; Akagi S; Hamamoto S Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582 [No Abstract] [Full Text] [Related]
17. [A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy]. Hayashi H; Beppu T; Ishiko T; Mizumoto T; Masuda T; Okabe K; Baba Y; Okabe H; Takamori H; Kanemitsu K; Hiroto M; Baba H Gan To Kagaku Ryoho; 2006 Nov; 33(12):1941-3. PubMed ID: 17212153 [TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers. Lee CH; Hsieh SY; Chang CJ; Lin YJ J Gastroenterol Hepatol; 2013 Jan; 28(1):122-7. PubMed ID: 23034166 [TBL] [Abstract][Full Text] [Related]
19. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver. Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969 [TBL] [Abstract][Full Text] [Related]
20. Independent occurrence of hepatocellular and cholangiocellular cancer nodules in the liver. Furuta T; Kanematsu T; Sonoda T; Sugimachi K Eur J Surg Oncol; 1987 Feb; 13(1):69-73. PubMed ID: 3028868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]